摘要
目的:了解武警江苏省总队医院(以下简称"我院")抗肿瘤药的临床应用情况及发展趋势,为临床合理用药提供参考。方法:采用销售金额排序法、用药频率(defined daily dose system,DDDs)排序法和限定日费用(daily drug cost,DDC)排序法对我院2012—2014年抗肿瘤药用药数据进行统计、分析。结果:我院2012—2014年抗肿瘤药销售总金额和使用总频率呈逐年增长趋势,单个药物3年中DDC波动幅度较小,总体趋于稳定。其中,多西他赛、奥沙利铂、吉西他滨和帕米膦酸3年中销售金额一直位于前5名内,使用频率较高的药物为氟尿嘧啶和顺铂,交替出现在DDDs排序前2位。结论:我院抗肿瘤药应用情况基本合理,但仍需对抗肿瘤药物的应用管理,进一步加强临床用药的合理应用。
OBJECTIVE： To investigate the status quo and development tendency of anti-tumor drugs in the Armed Police Corps Hospital of Jiangsu Province（ hereinafter referred to as our hospital）,and to provide reference for the rational drug use in clinic. METHODS： The medication data of anti-tumor drugs in our hospital during 2012-2014 were statistically analyzed by using consumption sum ranking method,defined daily dose system（ DDDs） ranking method and defined daily cost（ DDC） ranking method. RESULTS： The consumption sum and DDDs of anti-tumor drugs had an increasing trend year by year in our hospital during 2012-2014. The DDC of single drug had a small volatility but it was stable in general. Docetaxel,oxaliplatin,gemcitabine and pamidronate dominated the top 5 places ranked by consumption sum during the three years,meanwhile,fluorouracil and cisplatin both had high application frequency,which were listed on the top 2 in turn ranked by DDDs. CONCLUSIONS： The current status of anti-tumor drugs is basically rationally in our hospital,but the monitoring on clinical application of anti-tumor drugs still needs to be intensified,so as to further strengthen the rational drug use in clinic.
出处
《中国医院用药评价与分析》
2015年第10期1350-1352,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
